Download copies of past BPM Summit program books:

2013 2014 2015
    Track 1 Track 2

March 28, 2017

7:00 AM
7:00 AM - 4:30 PM
7:00 AM
 7:00 AM - 8:00 AM
8:00 AM
Pioneering Precision: Industry's Move Toward a Targeted Era

Welcome and Introductory Remarks

Christopher J. Wells, MPA, Director, Communications, Personalized Medicine Coalition

8:00 AM - 8:25 AM
8:30 AM
Opening Keynote

Nick Naclerio, PhD, Founder & Managing Partner, Illumina Ventures

8:30 AM - 9:00 AM
9:05 AM
Financing Strategies for Precision Medicine Ventures

Plenary Session

John Doulis, MD, Chief Informatics and Information Officer, MedCare Investment Funds

Manuel J. Glynias, President & Chief Executive Officer, GenomOncology

Samuel D. Riccitelli, President, Chief Executive Officer & Director, Signal Genetics

MODERATOR: Jeff Karan, Managing Partner, Mavericks Capital

9:05 AM - 9:55 AM
9:55 AM
Networking Break
9:55 AM - 10:25 AM
10:25 AM
Moving Targets: Strategies to Prepare for Reimbursement Trends and Changes in Payment Policies

Plenary Session

Anita J. Chawla, PhD, Managing Principal, Analysis Group

Mark McCoy, MBA, Senior Director, Reimbursement, Guardant Health, Inc.

Amber Trivedi, MS, CGC, Senior Vice President, Market Development and Innovation, InformedDNA

MODERATOR: Judith A. Waltz, Partner, Foley & Lardner LLP

10:25 AM - 11:15 AM
11:20 AM
Expanding the Possibilities of Personalized Medicine Through Collaborative Data Collection, Sharing, and Analysis

Plenary Session

Leeland Ekstrom, PhD, Managing Director, BioVU Partnerships, Vanderbilt University Medical Center & Founder, Nashville Biosciences

MODERATOR: Nicholas Donoghoe, MD, Partner, McKinsey & Company

11:20 AM - 12:10 PM
12:10 PM
12:10 PM - 1:10 PM
1:10 PM
Pushing the Envelope: Innovative Next-Generation Sequencing Technologies and Applications

Breakout Session - Track 1

MODERATOR: Ashley Van Zeeland, PhD, MBA, Chief Technology Officer, Human Longevity, Inc.

1:10 PM - 2:00 PM
Clinical Adoption Challenges and Solutions from Big Pharma's Perspective

Breakout Session - Track 2

Maurie Markman, MD, President of Medicine and Science, Cancer Treatment Centers of America

MODERATOR: Kalidip “KC” Choudhury, PhD, Vice President. Business Development, XBiotech

1:10 PM - 2:00 PM
2:05 PM
Creating a Coordinated Path Forward: Biomarkers in Drug Discovery and Clinical Practice

Breakout Session - Track 1

Mark Frasier, PhD, Senior Vice President, Research Programs, The Michael J. Fox Foundation for Parkinson's Research

Sally A. Howard, JD, Head of Regulatory Affairs and Policy, Human Longevity, Inc.

MODERATOR: Christine Meda, Chief Business Officer, IncellDx

2:05 PM - 2:55 PM
Launching a Precision Medicine Program: Real-World Solutions to Practical Challenges

Breakout Session - Track 2

Anna B. Berry, MD, Scientific Director of Personalized Medicine, Swedish Cancer Institute & Medical Director of Molecular Diagnostics, CellNetix Pathology and Laboratories

Timothy L. Cannon, MD, Medical Oncologist & Hematologist, Inova Medical Group

Brad Perkins, MD, MBA, Chief Medical Officer, Human Longevity, Inc.

MODERATOR: Jennifer Levin Carter, MD, MPH, Chief Medical Officer & Founder, N-of-One

2:05 PM - 2:55 PM
3:00 PM
Closing Keynote

Lucian Iancovici, MD, General Partner, dRx Capital AG

Aaron Nelson, MD, PhD, General Partner, dRx Capital AG

3:00 PM - 3:30 PM
3:30 PM
Networking Break
3:30 PM - 4:00 PM
4:00 PM
First Pitch: Personalized Medicine

NEW FOR 2017! Seed to Series A Startup, Investor, and Researcher Demo Day Presented by the California Technology Council

4:00 PM - 6:00 PM
6:00 PM
Closing Reception
6:00 PM - 7:00 PM